Jill Harvilchuk

A Research Leader for the Highly Toxic Materials group at the Battelle Biomedical Research Center (BBRC). Her work focuses primarily on development of countermeasures for chemical warfare agents such as nerve agents. As a Research Leader, she ensures that studies are properly designed for FDA approval of the medical countermeasure. Since joining Battelle in 2009, she has worked on dozens of studies involving chemical and biological threat agents, including anthrax, soman and other highly toxic or pathogenic agents. She recently completed a large animal radiolabeled ADME (absorption, distribution, metabolism and excretion) study that provided new insights on where toxic compounds end up in the body and how they are broken down that will guide development of future countermeasures.